To further validate the role of the MGAT1-CD73 axis in immune checkpoint blockade responses, we conducted gain- and loss-of-function experiments in MGAT1-KD, MGAT1-OE, and CD73-4NQ tumor models (Supplementary Fig. 11a–f). This evidence concerns the gene NT5E and neoplasm.